Cargando…
3D-QSAR and Molecular Docking Studies on Fused Pyrazoles as p38α Mitogen-Activated Protein Kinase Inhibitors
The p38α mitogen-activated protein kinase (MAPK) has become an attractive target for the treatment of many diseases such as rheumatoid arthritis, inflammatory bowel disease and Crohn’s disease. In this paper, 3D-QSAR and molecular docking studies were performed on 59 p38α MAPK inhibitors. Comparativ...
Autores principales: | Lan, Ping, Huang, Zhi-Jian, Sun, Jun-Rong, Chen, Wei-Min |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956100/ https://www.ncbi.nlm.nih.gov/pubmed/20957100 http://dx.doi.org/10.3390/ijms11093357 |
Ejemplares similares
-
2D-QSAR Modeling and Molecular Docking Studies on
1H-Pyrazole-1-carbothioamide Derivatives as
EGFR Kinase Inhibitors
por: Hajalsiddig, Tawassl T. H., et al.
Publicado: (2020) -
Design and Synthesis of Aminopyrimidinyl Pyrazole Analogs as PLK1 Inhibitors Using Hybrid 3D-QSAR and Molecular Docking
por: Bhujbal, Swapnil P., et al.
Publicado: (2022) -
A New Pathway for the Preparation of Pyrano[2,3-c]pyrazoles and molecular Docking as Inhibitors of p38 MAP
Kinase
por: Nguyen, Hai Truong, et al.
Publicado: (2022) -
Redox-dependent dimerization of p38α mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3
por: Bassi, Rekha, et al.
Publicado: (2017) -
Use of QSAR Global Models and Molecular Docking for Developing New Inhibitors of c-src Tyrosine Kinase
por: Ancuceanu, Robert, et al.
Publicado: (2019)